A new survey from Mexico indicates children suffering from varied forms of neurodegenerative conditions, like refractory epilepsy (RE), have dramatically reduced their convulsions with the use of cannabidiol – a.k.a. CBD.
Directed by Dr. Carlos Velasquez of The Monterrey Institute of Technology and Higher Education – a March 2017 study of a Latin America survey reveals that of the 43 Mexican pediatric cases treated with CBD oil, 81.3% of surveyed parents reported a noteworthy decrease in RE related convulsions.
A form of drug-resistant epilepsy, only 5% of those individuals afflicted with RE manage to find help on an annual basis.
Reduction in Refractory Epilepsy Convulsions
Published in Neurology Research International, the survey discovered that of the 43 Mexican pediatric RE cases treated with a hemp based CBD oil, 51% showed a “significant decrease” in convulsions of more than 75%; an additional 16% reported their children were entirely free of seizures. Representing the first study of its kind carried out in Mexico, of the 43 surveyed cases, 9 dramatically reduced their use of antiepileptic drugs – with “no serious side effects reported.”
The results of this study indicate that, from the viewpoint of the parents of children with RE, medicinal cannabis is useful as an “add on” treatment for their children since it induces a significant reduction in the frequency, duration, and intensity of seizures. It also improved aspects of the patients’ quality of life in terms of their emotional and cognitive states, their sleep patterns, and their diet. There was an absence of serious adverse effects, with only some tolerable mild adverse effects experienced with this CBD-based treatment.
A prolific problem for people around the globe, epilepsy is a neurological disorder that currently affects over 50 million people worldwide. Of those affected, 30 % to 40% suffer with intractable seizures and are unresponsive to antiepileptic treatments. Offering hope to the hopeless, research into the CBD cannabinoid could soon provide the key to a seizure-free life for millions.
In the below YouTube video, Dr. Elizabeth Thiele, Director of the Pediatric Epilepsy Center at Massachusetts General Hospital, Director of the Carol and James Herscot Center for Tuberous Sclerosis Complex, and Professor of neurology at Harvard Medical School, sat down with Neurology Advisor to discuss the state of cannabidiol research for the treatment of refractory epilepsy.